FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...
Breast cancer is one of the most-researched illnesses in the world. But some men suffering from the disease say they’re not able to benefit from new research and treatments.
AstraZeneca has announced that FluMist has been approved in the US as the self-administered influenza vaccine. FluMist, a ...
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
The FDA Friday approved the flu vaccine that can be done at home and does not need to be administered by a health care provider.
The FDA is clearing the way for an at-home flu vaccines. A self-administered version of pharmaceutical giant AstraZeneca’s ...
The Food and Drug Administration on Friday approved the first at-home flu vaccine, a nasal spray that consumers with a ...
The FDA authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a prescription.
The most recent trading session ended with Astrazeneca (AZN) standing at $78.38, reflecting a -0.66% shift from the previouse trading day's closing. The stock's change was less than the S&P 500's ...
22h
Missouri healthcare worker who had contact with a hospitalized patient infected with bird flu developed mild respiratory ...
In a first, the US Food and Drug Administration on Friday approved a nasal spray flu vaccine for self-administration.
FluMist is the only flu vaccine administered by nasal spray, not injection. It is licensed for individuals between the ages ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback